BIO Protocol announced via a post on X that Long COVID Labs launches tomorrow, January 9, and it will accelerate a cure with DeSci.
The ticker of the project will be COVID and contributors include current and ex-Stanford researchers. The project will distribute 1% of the token supply to BIO holders who take part in the auction.
The project revealed via X important details about their vision, starting by saying that even if COVID-19 left the headlines, it never left peoples’ bodies. They addressed that 20% of recovered patients still have viral remnants including spike proteins in their bloodstream.
Also, they noted that 40% of people diagnosed with long Covid suffer from chronic illness.
Long COVID Labs was reportedly created to tackle these challenges with a bold vision:
The founders of the project include the following specialists:
In the X thread, the project claims to be the largest decentralized trial network ever built, involving machine learning that:
The project also noted that while Big Pharma ruled medicine for decades, profiting from slow and expensive processes that prioritize investors over patients, now Long COVID Labs will change this paradigm, focusing on patients.
The project uses a DAO model where individuals/patients hold governance tokens (COVID) that allow them to vote on proposals, recommend research directions, and oversee financial proceeds.
There are two ways to earn COVID tokens:
The BIO Protocol was announced as Binance Launchpool’s 63rd project in December 2024.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.